Genome & Company314130 
$2.760.27%24h
0.27%24h
Global rank26644
Market cap$38.91M
Change 7d-
YTD Performance-71.20%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Genome & Company (314130)
As of November 2024, Genome & Company has a market cap of $38.91M. This makes Genome & Company the world's 26644th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Genome & Company from 2021 to 2024
-
Value:-
Market cap history of Genome & Company from 2021 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $99.29M | -25.22% |
| 2023 | $132.78M | -28.42% |
| 2022 | $185.51M | -50.00% |
| 2021 | $371.02M | - |
314130 Market Cap Today is $38.91M 0.27% - 21 Nov 2024
View largest stocks by market cap 
